182 related articles for article (PubMed ID: 33063838)
1. Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.
Liu L; Al-Dhamin Z; Yuan X; Cui L; Yang Y; Zhao W; Zhang Y; Fu N; Nan Y
Histol Histopathol; 2020 Nov; 35(11):1309-1318. PubMed ID: 33063838
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.
Qian X; Zheng S; Wang L; Yao M; Guan G; Wen X; Zhang L; Xu Q; Chen X; Zhao J; Duan Z; Lu F
Dis Markers; 2019; 2019():3862024. PubMed ID: 31636735
[TBL] [Abstract][Full Text] [Related]
3. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
4. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
5. Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease.
Liu L; Wang J; Feng J; Yao M; Hao C; You Y; Yan Y; Gong J; Lu Y; Xie X; Zhang M; Chen L; Li T; Lu F; Wang JS
Sci Rep; 2018 Nov; 8(1):16730. PubMed ID: 30425268
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.
Yao M; Wang L; Leung PSC; Li Y; Liu S; Wang L; Guo X; Zhou G; Yan Y; Guan G; Chen X; Bowlus CL; Liu T; Jia J; Gershwin ME; Ma X; Zhao J; Lu F
Clin Rev Allergy Immunol; 2018 Apr; 54(2):282-294. PubMed ID: 29256057
[TBL] [Abstract][Full Text] [Related]
7. [The diagnostic potential of Golgi protein 73 for cirrhosis in patients with chronic hepatitis C].
Wang PF; Liu SH; Qian XJ; Zhai XW; Wen XJ; Yao MJ; Zhao FM; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):879-884. PubMed ID: 36207945
[No Abstract] [Full Text] [Related]
8. Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.
Xu Z; Shen J; Pan X; Wei M; Liu L; Wei K; Liu L; Yang H; Huang J
J Med Virol; 2018 Jun; 90(6):1053-1062. PubMed ID: 29424455
[TBL] [Abstract][Full Text] [Related]
9. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.
Xu Z; Liu L; Pan X; Wei K; Wei M; Liu L; Yang H; Liu Q
Medicine (Baltimore); 2015 Mar; 94(12):e659. PubMed ID: 25816035
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of novel hepatic fibrosis markers in assessing cirrhosis in patients with chronic hepatitis C].
Kang Q; Liu JX; Tan N; Chen HY; Pan JL; Han YF; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):56-64. PubMed ID: 36948850
[No Abstract] [Full Text] [Related]
11. [A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease].
An XY; Qiao J; Hu LX; Wang RQ; Nan YM
Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):49-53. PubMed ID: 36631037
[No Abstract] [Full Text] [Related]
12. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
13. [Establishment and preliminary application of serum Golgi protein 73 based noninvasive diagnostic model for compensated stage hepatitis B cirrhosis].
Zhai XW; Liu SH; Yao MJ; Qian XJ; Wen XJ; Xu Q; Zhao JM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):47-52. PubMed ID: 32023699
[No Abstract] [Full Text] [Related]
14. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
15. Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection.
Cao Z; Li Z; Wang H; Liu Y; Xu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Cai W; Liu L; Bao S; Xie Q
Liver Int; 2017 Nov; 37(11):1612-1621. PubMed ID: 28772348
[TBL] [Abstract][Full Text] [Related]
16. GP73 level in patients with chronic hepatitis B: Relationship with liver biopsy, levels of ALT, AST and HBV DNA.
Atilla A; Taşkın MH; Kazak Z; Aydın S; Kılıç SS
Indian J Pathol Microbiol; 2022; 65(1):55-58. PubMed ID: 35074966
[TBL] [Abstract][Full Text] [Related]
17. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
18. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
[TBL] [Abstract][Full Text] [Related]
20. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
